Modified Folfirinox for Pancreatic Cancer
This trial will compare two chemotherapy regimens for pancreatic cancer. It will also study how well the cancer responds to different treatments, and look for biomarkers that could predict treatment response.
- Pancreatic Cancer
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
What are the chief medical benefits of Modified Folfirinox?
"Carcinomas such as non-small cell lung carcinoma, rectal carcinoma, and other malignant neoplasms can be managed through Modified Folfirinox."
How many willing individuals are part of this experiment?
"Yes, the clinicaltrials.gov website contains information showing that this trial is still looking for participants. The listing was first posted on October 14th 2020 and updated most recently on April 12th 2022. So far, 150 patients have been recruited from 6 different locations."
Are there any dangers patients should know about before taking Modified Folfirinox?
"While there is some data suggesting that the Modified Folfirinox intervention is safe, none of it points to the efficacy of the treatment. Therefore, our team has given it a score of 2."
Can you tell me what other research studies have been done that are similar to this one using Modified Folfirinox?
"Currently, 1700 clinical trials are underway to study the effects of modified Folfirinox. 495 of those trials are in Phase 3. Most of the studies for Modified Folfirinox are based in Guangzhou, Guangdong; however, there are 83029 locations running similar studies."
Are participants still being recruited for this research project?
"That is correct. The clinicaltrials.gov website has information indicating that this trial, which was first advertised on October 14th 2020, is still looking for participants. They need a total of 150 patients from 6 different locations."
Is this trial active in several places throughout North America?
"There are six sites currently running this trial, three of which are located in Baltimore, Boston and Vancouver. The other locations may be closer to you, lessening the inconvenience of travel should you choose to participate."